Biocon Merges Biologics Unit, Plans Rs 4,500 Cr Fundraise
Biocon announces merger of its biologics subsidiary with the parent company and a major Rs 4,500 crore fundraise. Explore the strategic shift and its impact on India's biotech sector.
Category : Search result: Biocon
Biocon Integrates Biologics Arm in $5.5 Billion Share Swap
Biocon announces full integration of its biosimilars unit, Biocon Biologics, in a deal valuing it at $5.5 billion. The move aims to create a unified powerhouse in diabetes, oncology, and immunology markets. Read more.
Kiran Mazumdar Shaw criticized for Bengaluru praise
Biocon's Kiran Mazumdar Shaw faces online criticism after praising Bengaluru's infrastructure improvements. Residents dispute claims about roads and footpaths. Read more about the controversy.
Biocon Hits 52-Week High on Biologics Restructuring News
Biocon stock jumps over 4% as company reviews Biologics IPO and merger options to unlock shareholder value and reduce debt. Latest market updates and analysis.
Biocon Banks on Weight-Loss Drugs, Ups Biosimilar Stake
Biocon's generics business surges 24% driven by weight-loss drugs liraglutide & semaglutide. CEO Siddharth Mittal reveals strategy to capture share of the booming $95 billion GLP-1 market.
3 Hot Stocks to Buy Now: Expert Short-Term Picks
Religare Broking's Ajit Mishra reveals 3 promising stocks for short-term traders. Discover why Nestlé India, Biocon, and this infrastructure player could deliver quick returns in current market conditions.
Bengaluru Leaders Meet Deputy CM After Infrastructure Criticism
Top industry leaders hold crucial meeting with DK Shivakumar to address Bengaluru's infrastructure crisis following their public criticism of the city's deteriorating conditions.
Kiran Mazumdar-Shaw: "I Am a Proud Kannadiga"
Biocon founder Kiran Mazumdar-Shaw delivers powerful response to online trolls questioning her Kannadiga identity, reaffirming her deep roots in Karnataka with inspiring conviction.
Kiran Mazumdar-Shaw denies fake road repair reports
Biocon Executive Chairperson Kiran Mazumdar-Shaw has vehemently denied fabricated reports claiming she offered to repair Bengaluru's roads, calling out misinformation circulating on social media.
Kiran Mazumdar-Shaw: I am a proud Kannadiga
Biocon founder Kiran Mazumdar-Shaw delivers powerful response to online trolls questioning her Kannadiga identity and commitment to Karnataka. Read her emotional defense of her roots.
Biocon's US Insulin Move with Civica Partnership
Indian pharmaceutical leader Biocon Biologics partners with Civica to disrupt US insulin market with affordable alternatives, while also eyeing anti-obesity therapy opportunities.
Mazumdar-Shaw meets Shivakumar amid Bengaluru infra concerns
Biocon chief Kiran Mazumdar-Shaw met with Karnataka Deputy CM DK Shivakumar, extending Diwali wishes while discussing Bengaluru's pressing infrastructure challenges in a cordial meeting.
Mazumdar-Shaw meets Shivakumar, extends Diwali greetings
Biocon chief Kiran Mazumdar-Shaw extends Diwali wishes to Karnataka Deputy CM DK Shivakumar during cordial meeting, signaling potential thaw in ongoing Bengaluru infrastructure discussions.
Mazumdar-Shaw Claps Back in Bengaluru Infrastructure Row
Biocon chief Kiran Mazumdar-Shaw defends her criticism of Bengaluru's crumbling infrastructure as Karnataka Deputy CM DK Shivakumar attacks her remarks. The war of words exposes the city's ongoing urban crisis.
Biocon chief denies Karnataka deputy CM's allegations
Biocon Executive Chairperson Kiran Mazumdar-Shaw firmly denies Karnataka Deputy CM DK Shivakumar's claims about the company's Bengaluru expansion plans, asserting their commitment to the state is unwavering.
Bengaluru Infrastructure War: DK Shivakumar vs Kiran Mazumdar-Shaw
Karnataka Deputy CM DK Shivakumar gives a sharp retort to Biocon chief Kiran Mazumdar-Shaw's criticism of Bengaluru's infrastructure, challenging her to develop roads herself in this escalating urban development debate.
Page 1 of 1